Product Infringement definition

Product Infringement has the meaning set forth in Section 9.4(a).

Product Infringement has the meaning set forth in Section 5.3.1.

Product Infringement shall have the meaning set forth in Section 13.4(a).

Examples of Product Infringement in a sentence

• ARS shall have the sole right, but not the obligation, to bring and control any action or proceeding to enforce or defend against any Infringement of the ARS Patents or Joint Patents that is not a Product Infringement [***] and shall be entitled to retain all recoveries therefrom.

• Except as otherwise agreed by the Parties in writing, any recovery or damages realized as a result of such action or proceeding with respect to Product Infringement pursuant to Section 9.3(b) shall be [***].

• The enforcing Party shall keep the non-enforcing Party reasonably informed of the status of any action it brought in connection with such Product Infringement.

• For any Product Infringement of a Foreground Patent, as between the Parties, Novartis will have the sole right, but not the obligation, to bring and control any legal action in connection with any such infringement, misappropriation, or other violation at its expense, including settling such action, as it reasonably determines appropriate.

More Definitions of Product Infringement

Product Infringement has the meaning set forth in Section 7.4(b).

Product Infringement has the meaning set forth in Section 8.3(a) (Patent Enforcement).

Product Infringement is defined in Section 10.3(a).

Product Infringement means any infringement or threatened infringement by a Third Party of any Licensed Patent, which infringing activity involves the using, making, importing, offering for sale or selling of a Licensed Product.

Product Infringement is defined in Section 6.3.1.

Product Infringement shall have the meaning set forth in Section 3.4(a)(i) hereof.

Product Infringement has the meaning set forth in Section 6.3(b). 1.68 “Program” means, as applicable, the TCR Program and the NK Cells and Gamma Delta T Cell Program. 1.69 “Regulatory Approval” means all approvals that are necessary for the commercial sale of product in the applicable field in a given country or regulatory jurisdiction. 1.70 “Regulatory Authority” means, in a particular country or jurisdiction, any applicable Governmental Authority involved in granting Regulatory Approval in such country or jurisdiction. 1.71 “Regulatory Materials” means regulatory applications, submissions, notifications, communications, correspondence, registrations, Regulatory Approvals and/or other filings made to, received from or otherwise conducted with a Regulatory Authority in order to Develop, manufacture, market, sell or otherwise Commercialize a Licensed Product in a particular country or jurisdiction. 1.72 “Releasees” has the meaning set forth in Section 3.4(a). 1.73 “Released Claims” has the meaning set forth in Section 3.4(a). 1.74 “Research” means non-clinical studies of a product conducted before the filing of an IND for such product. 1.75 “Sleeping Beauty Intellectual Property” means patent families [*****] and [*****] as detailed in Exhibit A. 1.76 “Sublicensee” means any Third Party granted a sublicense, covenant not to sue, forbearance agreement, co-promotion agreement or other similar arrangement (a “Sublicense”) by Alaunos to the rights licensed to Alaunos under Section 2.1(a) or Section 2.1(b). 1.77 “T-Cell” means a T-lymphocyte, including alpha beta T cells and gamma delta T cells. 1.78 “TCR” means T-cell receptor complex. 1.79 “TCR Exclusive Product” means any biological product, process or therapy that includes a TCR for a Neo-antigen, including all forms, formulations, presentations, doses, administrations and package configurations. 1.80 “TCR Exclusive Program” means a program(s) of Research and Development focused on Developing TCRs designed for Neo-antigens.